ZA200900316B - Antagonists of endothelial differentiation gene subfamily 3 (EDG-3, S1P3) receptors for prevention and treatment of ocular disorders - Google Patents
Antagonists of endothelial differentiation gene subfamily 3 (EDG-3, S1P3) receptors for prevention and treatment of ocular disordersInfo
- Publication number
- ZA200900316B ZA200900316B ZA200900316A ZA200900316A ZA200900316B ZA 200900316 B ZA200900316 B ZA 200900316B ZA 200900316 A ZA200900316 A ZA 200900316A ZA 200900316 A ZA200900316 A ZA 200900316A ZA 200900316 B ZA200900316 B ZA 200900316B
- Authority
- ZA
- South Africa
- Prior art keywords
- edg
- antagonists
- receptors
- prevention
- treatment
- Prior art date
Links
- 102100025747 Sphingosine 1-phosphate receptor 3 Human genes 0.000 title 2
- 102000036530 EDG receptors Human genes 0.000 title 1
- 108091007263 EDG receptors Proteins 0.000 title 1
- 101000693269 Homo sapiens Sphingosine 1-phosphate receptor 3 Proteins 0.000 title 1
- 208000022873 Ocular disease Diseases 0.000 title 1
- 101710155457 Sphingosine 1-phosphate receptor 3 Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 108020003175 receptors Proteins 0.000 title 1
- 102000005962 receptors Human genes 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83308006P | 2006-07-25 | 2006-07-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200900316B true ZA200900316B (en) | 2010-05-26 |
Family
ID=38982306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200900316A ZA200900316B (en) | 2006-07-25 | 2007-07-25 | Antagonists of endothelial differentiation gene subfamily 3 (EDG-3, S1P3) receptors for prevention and treatment of ocular disorders |
Country Status (11)
Country | Link |
---|---|
US (2) | US20080025973A1 (zh) |
EP (1) | EP2068856A2 (zh) |
JP (1) | JP2009544734A (zh) |
KR (1) | KR20090033886A (zh) |
CN (1) | CN101505744A (zh) |
AU (1) | AU2007279311A1 (zh) |
BR (1) | BRPI0714593A2 (zh) |
CA (1) | CA2657480A1 (zh) |
MX (1) | MX2009000907A (zh) |
WO (1) | WO2008014338A2 (zh) |
ZA (1) | ZA200900316B (zh) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2396982C2 (ru) | 2004-07-16 | 2010-08-20 | Киорин Фармасьютикал Ко., Лтд. | Эффективный способ использования лекарственных средств и способ предотвращения выраженности побочных эффектов |
BRPI0516337A (pt) | 2004-10-12 | 2008-04-29 | Kyorin Seiyaku Kk | processo para a produção de 2- amino-2-[4-(3-benziloxifeniltio) -2- (clorofenil} etil] - 1,3 - hidrocloreto de propanediol e hidratos dos mesmos e produtos intermerdiários para a produção dos mesmos |
CA2624909C (en) * | 2005-10-07 | 2013-10-01 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease |
TWI389683B (zh) * | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
RS53080B (en) * | 2006-08-08 | 2014-06-30 | Kyorin Pharmaceutical Co. Ltd. | AMINOPHOSPHORIC ACID ETHAR DERIVATIVE AND S1P RECEPTOR MODULATOR CONTAINING THE SAME AS THE ACTIVE INGREDIENT |
MY146775A (en) * | 2006-08-08 | 2012-09-28 | Kyorin Seiyaku Kk | Amino alcohol derivative and immunosuppressive agent having same as an active ingredient |
WO2009099174A1 (ja) | 2008-02-07 | 2009-08-13 | Kyorin Pharmaceutical Co., Ltd. | アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤 |
AU2009225747A1 (en) * | 2008-03-17 | 2009-09-24 | Allergan, Inc. | S1P3 receptor inhibitors for treating inflammation |
US20120071448A1 (en) * | 2009-05-05 | 2012-03-22 | Allergan, Inc. | S1P3 Receptor Inhibitors for Treating Conditions of the Eye |
JP2013501794A (ja) * | 2009-08-11 | 2013-01-17 | アラーガン インコーポレイテッド | 目の疾患を治療するためのイソチオゾール |
SG179143A1 (en) * | 2009-09-30 | 2012-05-30 | Stiefel Res Australia Pty Ltd | Cosmetic foam |
CN102146411B (zh) * | 2011-01-06 | 2013-01-02 | 中国人民解放军第三军医大学第三附属医院 | 新型双功能抗瘢痕和组织纤维化寡聚核苷酸药物 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995013811A1 (de) * | 1993-11-17 | 1995-05-26 | Byk Nederland Bv | Verwendung substituierter thiazolidinderivate zur behandlung von erhöhtem augeninnendruck |
US5545626A (en) * | 1994-01-19 | 1996-08-13 | The Trustees Of Columbia University In The City Of New York | Method of treating glaucoma with oligonucleotides |
US5750652A (en) * | 1994-01-21 | 1998-05-12 | Yale University | Deltex proteins |
EP1253929B1 (en) * | 2000-02-09 | 2007-05-23 | BAS Medical, Inc. | Use of relaxin to treat diseases related to vasoconstriction |
JP2001261575A (ja) * | 2000-03-13 | 2001-09-26 | General Hospital Corp | 血管収縮を調節する方法とその組成物 |
JP2002332278A (ja) * | 2001-05-08 | 2002-11-22 | Human Science Shinko Zaidan | Edg受容体拮抗作用を有する複素環誘導体 |
AU2003221762B2 (en) * | 2002-04-30 | 2008-09-25 | Alcon, Inc. | Agents which regulate, inhibit or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
WO2004010949A2 (en) * | 2002-07-30 | 2004-02-05 | University Of Virginia Patent Foundation | Compounds active in spinigosine 1-phosphate signaling |
EP1545517A1 (en) * | 2002-08-28 | 2005-06-29 | Merck Frosst Canada & Co. | Oxazolidin-2-one and thiazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of glaucoma |
FR2845003A1 (fr) * | 2002-09-30 | 2004-04-02 | Merck Sante Sas | Utilisation de derives de thiazolidinedione comme inhibiteurs de l'aldose reductase |
US20060173046A1 (en) * | 2003-07-15 | 2006-08-03 | Bell Ian M | Hydroxypyridine cgrp receptor antagonists |
JP2005247691A (ja) * | 2004-03-01 | 2005-09-15 | Toa Eiyo Ltd | S1p3受容体拮抗薬 |
US7888527B2 (en) * | 2004-12-06 | 2011-02-15 | University Of Virginia Patent Foundation | Aryl amide sphingosine 1-phosphate analogs |
RU2424227C2 (ru) * | 2005-10-12 | 2011-07-20 | Тоа Эйо Лтд. | Антагонист рецептора s1p3 |
CN101460458A (zh) * | 2006-02-15 | 2009-06-17 | 阿勒根公司 | 具有1-磷酸-鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚-3-羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物 |
-
2007
- 2007-07-25 ZA ZA200900316A patent/ZA200900316B/xx unknown
- 2007-07-25 AU AU2007279311A patent/AU2007279311A1/en not_active Abandoned
- 2007-07-25 WO PCT/US2007/074351 patent/WO2008014338A2/en active Application Filing
- 2007-07-25 KR KR1020097002077A patent/KR20090033886A/ko not_active Application Discontinuation
- 2007-07-25 MX MX2009000907A patent/MX2009000907A/es not_active Application Discontinuation
- 2007-07-25 JP JP2009521989A patent/JP2009544734A/ja active Pending
- 2007-07-25 CN CNA2007800311386A patent/CN101505744A/zh active Pending
- 2007-07-25 CA CA002657480A patent/CA2657480A1/en not_active Abandoned
- 2007-07-25 US US11/828,137 patent/US20080025973A1/en not_active Abandoned
- 2007-07-25 BR BRPI0714593-4A patent/BRPI0714593A2/pt not_active IP Right Cessation
- 2007-07-25 EP EP07813352A patent/EP2068856A2/en not_active Withdrawn
-
2010
- 2010-03-29 US US12/749,331 patent/US20100183629A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2007279311A1 (en) | 2008-01-31 |
JP2009544734A (ja) | 2009-12-17 |
EP2068856A2 (en) | 2009-06-17 |
WO2008014338A3 (en) | 2008-12-24 |
CN101505744A (zh) | 2009-08-12 |
US20080025973A1 (en) | 2008-01-31 |
KR20090033886A (ko) | 2009-04-06 |
US20100183629A1 (en) | 2010-07-22 |
WO2008014338A2 (en) | 2008-01-31 |
MX2009000907A (es) | 2009-02-04 |
BRPI0714593A2 (pt) | 2013-05-07 |
CA2657480A1 (en) | 2008-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200900316B (en) | Antagonists of endothelial differentiation gene subfamily 3 (EDG-3, S1P3) receptors for prevention and treatment of ocular disorders | |
IL186598A0 (en) | Composition and method for the treatment or prevention of glaucoma and ocular hypertension | |
WO2007112322A3 (en) | Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity | |
PL2019683T5 (pl) | Podawanie czynników wzrostu do leczenia zaburzeń OUN | |
HK1166983A1 (zh) | 包含用於治療疾病或紊亂的化合物的固體形式,其組合物,及其用途 | |
EP1838320A4 (en) | CXCR4 ANTAGONISTS FOR THE TREATMENT OF MEDICAL PROBLEMS | |
EP1893216A4 (en) | METHOD AND COMPOSITIONS FOR THE TREATMENT OF EYE DISEASES | |
WO2008029276A8 (en) | Compositions and methods for the treatment of ophthalmic disease | |
WO2007003411A3 (en) | Kinin antagonists for treating bladder dysfunction | |
WO2007137071A3 (en) | Compositions of r(+) and s(-) pramipexole and methods of using the same | |
WO2006023460A3 (en) | COMPOUNDS HAVING β2 ADRENERGIC RECEPTOR AGONIST AND MUSCARINIC RECEPTOR ANTAGONIST ACTIVITY | |
PL2444079T3 (pl) | Kompozycje i sposoby leczenia chorób oczu | |
IL180108A0 (en) | Sulfamate and sulfamide derivatives for the treatment of epilepsy and related disorders | |
HUE039108T2 (hu) | Készítmények és eljárások szembetegségek kezelésére | |
PT2418201E (pt) | Formas polimorfas de (2s)-(4e)-n-metil-5-[3-(5- isopropoxipiridin)il]-4-penten-2-amina para o tratamento de distúrbios do sistema nervoso central | |
PL1706113T3 (pl) | Sposób wytwarzania chlorowodorku 4-(2-dipropyloaminoetylo)-1,3-dihydro-2H-indol-2-onu | |
IL187966A0 (en) | New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases | |
WO2007141284A3 (en) | Treatment of gastrointestinal disorders with cgrp antagonists | |
WO2007146349A3 (en) | Cgrp receptor antagonists | |
EP2056840A4 (en) | COMPOSITIONS, DEVICES AND METHODS OF TREATING MORBUS HUNTINGTON BY INTRA-CRANICAL LEVY FROM SIRNA | |
EP1899318A4 (en) | NEW AZETIDINE DERIVATIVES AS NEUROKININ RECEPTOR ANTAGONISTS FOR THE TREATMENT OF STOMACH DARM DISEASES | |
EP2064347A4 (en) | METHODS FOR THE IDENTIFICATION, EVALUATION AND TREATMENT OF PATIENTS WITH DC CHIMIOKINE RECEPTOR 2 (CCR-2) MEDIATION DISORDERS | |
EP2320939A4 (en) | TISSUE CALLICLE FOR THE TREATMENT OF PARKINSON DISEASE | |
ZA200904281B (en) | Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders | |
SG138567A1 (en) | Punctal plugs for the delivery of active agents |